ArticleAnnals of dermatology2026

Efficacy and Safety of Novel Botulinum Toxin Type A (Protoxin) in the Treatment of Moderate to Severe Glabellar Lines: A Multicenter, Randomized, Double-Blind, Active-Controlled Phase III Study.

Hyung Seok Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.